BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7511644)

  • 1. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells.
    Nandi D; Gross JA; Allison JP
    J Immunol; 1994 Apr; 152(7):3361-9. PubMed ID: 7511644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii.
    Hunter CA; Ellis-Neyer L; Gabriel KE; Kennedy MK; Grabstein KH; Linsley PS; Remington JS
    J Immunol; 1997 Mar; 158(5):2285-93. PubMed ID: 9036976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
    Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
    J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L; Shevach EM
    J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of murine NK cells by CD40 and CD86 (B7-2).
    Martín-Fontecha A; Assarsson E; Carbone E; Kärre K; Ljunggren HG
    J Immunol; 1999 May; 162(10):5910-6. PubMed ID: 10229827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta+ T lymphocytes.
    Sperling AI; Linsley PS; Barrett TA; Bluestone JA
    J Immunol; 1993 Dec; 151(11):6043-50. PubMed ID: 8245449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.
    Geldhof AB; Raes G; Bakkus M; Devos S; Thielemans K; De Baetselier P
    Cancer Res; 1995 Jul; 55(13):2730-3. PubMed ID: 7540948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA; Chizzonite R; Remington JS
    J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma.
    Walker W; Aste-Amezaga M; Kastelein RA; Trinchieri G; Hunter CA
    J Immunol; 1999 May; 162(10):5894-901. PubMed ID: 10229825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An age-related decrease in rescue from T cell death following costimulation mediated by CD28.
    Engwerda CR; Handwerger BS; Fox BS
    Cell Immunol; 1996 May; 170(1):141-8. PubMed ID: 8660810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
    Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
    J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.